About Us

With over 30 years of experience leading public and private companies, Roger has guided organizations through financings, M&A, and growth, closing more than $150 million in financings and completing over 40 acquisitions and divestitures.

His track record includes turning around companies such as Enerjet and Resorts of the Canadian Rockies, scaling startups like Rare Method and Jump On Flyaways, and leading cutting edge medical device companies like MagnetTx and Ocumetics.

CAREY F. KALMOWITZ is a founding shareholder of The Health Law Partners, P.C. Mr. Kalmowitz graduated from New York University Law School in 1994 and from Vassar College in 1989.
Mr. Kalmowitz is admitted to both the Michigan and New York Bar. He practices in all areas of healthcare law, with specific concentration on the corporate and financial aspects of healthcare, including structuring revenue-enhancing transactions among physicians and other healthcare providers, certificate of need, compliance investigations, corporate fraud and abuse/Stark and third party payment and reimbursement. In addition, Mr. Kalmowitz also practices in the following areas of health care law:
 

• Counsels physicians and physician groups on integration strategies, ancillary services, employment agreements, recruitment agreements, shareholder agreements, buy ins, buy outs, compliance, third party payor audits, and negotiating joint venture and hospital relationships.

• Advises healthcare providers regarding compliance matters including the Stark Law, Anti-kickback Statute and reimbursement regulations.

• Served as general counsel of major regional healthcare system, and has significant experience with the full spectrum of hospitals' legal issues.

• Assisted a variety of providers with certificate of need projects, including two replacement hospitals and numerous CT, MRI and ASC transactions.

• Advises long-term care facilities on compliance and business issues.

• Represents a variety of health care providers, including physicians, ambulatory surgery centers, long-term care facilities and durable medical equipment suppliers with a broad range of health care transactional issues.
   

Mr. Kalmowitz is a member of the State Bar of Michigan, the Michigan Society of Hospital Attorneys, the New York Health Law Section, the American Health Lawyer's Association, and the American Bar Association.

Mr. Kalmowitz has written extensively on subjects across the spectrum of health care law, including, co-authoring a monthly column in the Association for Medical Imaging Management's (AHRA) publication, Link, regarding up-to-date legal issues relevant to imaging providers and suppliers.

As Chief Physicist at Solaris Health, he oversees radiology and radiation therapy services for one of the largest urology groups in the United States. With more than 14 years of experience in medical physics, he brings expertise in radiology, radiation safety, and brachytherapy. His responsibilities include ensuring the quality and safety of radiation equipment, protocols, and procedures, as well as providing technical support and guidance to physicians and staff.

​

He also contributes to research and development in emerging radiation technologies and applications, including prostate seed implants and high dose rate brachytherapy. Dedicated to improving patient outcomes and quality of life for individuals with urologic cancers, he remains committed to advancing the standards and practices of medical physics within the healthcare industry.

Dr. Sehgal is a board-certified medical oncologist and hematologist, and serves as the Director of Medical Oncology at AdventHealth Winter Park. He specializes in treating a wide variety of cancers and disorders of the blood. 

​

Dr. Sehgal has published multiple peer-reviewed publications and received merit awards from the American Society of Clinical Oncology, American College of Physicians, and European Society of Clinical Oncology. He previously served as the Chief Medical Officer and Vice President of Medical Affairs at the University of Pittsburgh Medical Center. An internationally renowned physician, Dr. Seghal is committed to the comprehensive care of the whole patient — body, mind and spirit.

Dr. Shawn Zimberg is the Director of Radiation Oncology Services at Solaris Health. He brings to Solaris over 25 years of experience as an authority in strategic business development and management of radiation oncology practices, and financial and clinical optimization of multi-site and regional oncology facilities.

​

Dr. Zimberg was a founding partner of Integrated Medical Professionals, PLLC, a Solaris Health affiliate practice, and since 2006 has served a board member of IMP and Medical Director of its Advanced Radiation Centers of New York division.   Under his leadership, ARC has become the largest freestanding radiation oncology practice in the Metro New York Tri-State Region, and has developed an infrastructure and service line that provides physics, dosimetry and IT support to oncology practices across the nation.

​

Over his career, Dr. Zimberg has been at the forefront of deploying sophisticated radiation oncology technologies for brain, lung, head and neck, and prostate cancer treatments.  Dr. Zimberg has co-authored numerous peer-reviewed medical journal publications ranging from new technologies in the treatment of prostate cancer to medical economics of large group practice, and has been a principal investigator in clinical trials including several FDA pivotal trials evaluating cutting-edge technologies in cancer care.   He is routinely listed in Castle Connolly Regional Top Doctors in the New York area.

​

Dr. Zimberg received a BS degree from the University of Michigan, a MD degree from the University of Michigan Medical School, and completed his radiation oncology residency at Memorial Sloan-Kettering Cancer Center, where he was received the American Cancer Society’s Clinical Fellowship award.  He serves on the board of directors of the Association of Free-standing Radiation Oncology Centers (AFROC), and is a member of the Investment Advisory Board of Evolution Venture Partners, a healthcare investment bank focusing on biotechnology and life-sciences including oncology and cancer breakthroughs.